Cargando…
Protein Tyrosine Kinase Panel As a Tool for Anticancer Drug Design
The discovery of the pharmaceutical potential of small molecule inhibitors of oncogenic protein tyrosine kinases is one of the directions in target therapy in oncology. Presently, investigations aiming at developing new therapeutically important inhibitors have to be based on a combination of comput...
Autores principales: | Rakitina, T.V., Yudkina, O.V., Smirnova, E.V., Lipkin, A.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347529/ https://www.ncbi.nlm.nih.gov/pubmed/22649618 |
Ejemplares similares
-
Characteristics of Populations of the Russian Federation over the Panel of Fifteen Loci Used for DNA Identification and in Forensic Medical Examination
por: A Stepanov, V., et al.
Publicado: (2011) -
Recent developments in receptor tyrosine kinases targeted anticancer therapy
por: Raval, Samir H., et al.
Publicado: (2016) -
Novel Phthalic-Based Anticancer Tyrosine Kinase Inhibitors: Design, Synthesis and Biological Activity
por: Kalinichenko, Elena, et al.
Publicado: (2023) -
The tyrosine kinase v‐Src modifies cytotoxicities of anticancer drugs targeting cell division
por: Yuki, Ryuzaburo, et al.
Publicado: (2021) -
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
por: Gagic, Zarko, et al.
Publicado: (2020)